Quest Diagnostics Incorporated (NYSE: DGX), a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice ...

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

The 5 testing & diagnostics services stocks we track reported a very strong Q3. As a group, revenues beat analysts’ consensus ...

The company says it can turn profits without its customers facing the usual out-of-pocket costs or high premiums. Economists ...

During the year the industry saw continued consolidation, the end of a key advisory body, the rise in DTC testing and advanced diagnostics, and another stab at PAMA reform.

Polarized light is one of the most powerful tools scientists have for peering inside matter, yet the way it twists, scatters ...

Dr Simon Agwale is the Chief Executive of Innovative Biotech Nigeria and Innovative Biotech USA. He also serves as Chairman ...

Quest Diagnostics handles the blood and other biological specimens of one in three Americans every year, and in Temple ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...

In the U.S. there are more than 150 million emergency department (ED) visits each year, and the number is expected to rise. ED physicians face enormous pressure to quickly and correctly diagnose ...